Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.